Editorials A licence to cure BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1723 (Published 01 April 2015) Cite this as: BMJ 2015;350:h1723 Article Related content Metrics Responses Peer review Related articles Feature Attacks on publicly funded trials: what happens when industry does not want to know the answer Published: 01 April 2015; BMJ 350 doi:10.1136/bmj.h1701 Feature Why have UK doctors been deterred from prescribing Avastin? Published: 01 April 2015; BMJ 350 doi:10.1136/bmj.h1654 Editorial The problem of orphan drugs Published: 17 November 2010; BMJ 341 doi:10.1136/bmj.c6456 Editor's Choice A vote for the NHS Published: 02 April 2015; BMJ 350 doi:10.1136/bmj.h1754 News Minister rules out use of Avastin over Lucentis for wet AMD Published: 16 April 2015; BMJ 350 doi:10.1136/bmj.h2050 Letter Marketing regulations do not apply to individual clinicians Published: 21 April 2015; BMJ 350 doi:10.1136/bmj.h2071 See more High levels of bad cholesterol in early middle age are linked to CVD risk decades later, study finds BMJ December 04, 2019, 367 l6814; DOI: https://doi.org/10.1136/bmj.l6814 Two thirds of GP trainees have no plan to work full time after qualifying, survey finds BMJ December 03, 2019, 367 l6793; DOI: https://doi.org/10.1136/bmj.l6793 Helen Salisbury: Measuring continuity of care BMJ December 03, 2019, 367 l6567; DOI: https://doi.org/10.1136/bmj.l6567 Drastic action is needed to reverse falling GP numbers, says RCGP BMJ November 28, 2019, 367 l6751; DOI: https://doi.org/10.1136/bmj.l6751 Drug shortages are fuelling patient complaints, doctors warn BMJ November 28, 2019, 367 l6742; DOI: https://doi.org/10.1136/bmj.l6742 Cited by... Marketing regulations do not apply to individual cliniciansFulltext PDF
